FATE Operating Cash Flow Growth
Fate Therapeutics Inc · Operating Cash Flow Growth
FATE Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported11.82%period ending
FATE TTM Cash from Operations YoY % (-39.37% → 11.82%)
Year-over-year change
High-resolution chart · PNG
FATE operating cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow Growth |
|---|---|
| 11.8238% | |
| 16.4076% | |
| 13.6644% | |
| 16.0524% | |
| 17.7511% | |
| 9.8133% | |
| 7.0987% | |
| 22.9822% | |
| 25.1468% | |
| 35.632% | |
| 46.7128% | |
| 29.6559% | |
| 15.1964% | |
| -6.0223% | |
| -52.3964% | |
| -114.6855% | |
| -100.2188% | |
| -405.3642% | |
| -315.1775% | |
| -156.7823% | |
| -233.0794% | |
| 57.0657% | |
| 52.8356% | |
| 35.7705% | |
| 36.6051% | |
| -111.8623% | |
| -115.2005% | |
| -79.0305% | |
| -17.3027% | |
| -3.788% | |
| -4.7284% | |
| -13.6831% | |
| -42.231% | |
| -39.8821% | |
| -23.7468% | |
| -15.3649% | |
| -8.7916% | |
| -55.785% | |
| -62.108% | |
| -66.3273% | |
| -80.6837% | |
| 18.1189% | |
| 17.9401% | |
| 15.6503% | |
| 15.0208% | |
| -40.9943% | |
| -45.8336% | |
| -46.8955% | |
| -39.3697% |